NovaBay Pharmaceuticals Inc Cash Flow Conversion Efficiency
NovaBay Pharmaceuticals Inc cash flow conversion efficiency. Based on the latest financial reports, NovaBay Pharmaceuticals Inc (NBY) has a cash flow conversion efficiency ratio of 0.100x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.27 Million) by net assets ($-22.83 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of NovaBay Pharmaceuticals Inc (2005–2025)
Cash flow conversion efficiency of NovaBay Pharmaceuticals Inc from 2005 to 2025. This chart illustrates how NovaBay Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NBY stock price and chart for real-time trading data and today's change.
NovaBay Pharmaceuticals Inc Cash Flow Conversion Ratio Explained
NovaBay Pharmaceuticals Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
NovaBay Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NovaBay Pharmaceuticals Inc ranked by their cash flow conversion efficiency. Also see how much is NovaBay Pharmaceuticals Inc worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Orge Enerji Elektrik Taahhut AS
IS:ORGE
|
-0.032x |
|
Jiangsu Youli Investment Holding Co Ltd
SHE:000584
|
-0.138x |
|
Heerim Architects & Planners Co. Ltd
KQ:037440
|
0.008x |
|
IMS SA
WAR:IMS
|
0.157x |
|
Monalisa
KO:012690
|
0.021x |
|
Molecure S.A.
WAR:MOC
|
0.266x |
|
Hastings Technology Metals Ltd
AU:HAS
|
-0.035x |
|
Cnova NV
PA:CNV
|
-0.063x |
Annual Cash Flow Conversion Efficiency for NovaBay Pharmaceuticals Inc (2005–2025)
The table below shows the annual cash flow conversion efficiency of NovaBay Pharmaceuticals Inc from 2005 to 2025. Review free cash flow generation of NovaBay Pharmaceuticals Inc to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-22.83 Million | $-8.43 Million | 0.369x | -99.08% |
| 2024-12-31 | $-129.00K | $-5.18 Million | 40.178x | +3224.87% |
| 2023-12-31 | $3.31 Million | $-4.26 Million | -1.286x | -103.94% |
| 2022-12-31 | $10.55 Million | $-6.65 Million | -0.630x | +30.24% |
| 2021-12-31 | $10.17 Million | $-9.19 Million | -0.904x | -135.80% |
| 2020-12-31 | $12.32 Million | $-4.72 Million | -0.383x | +95.30% |
| 2019-12-31 | $973.00K | $-7.93 Million | -8.149x | -625.04% |
| 2018-12-31 | $4.95 Million | $-5.57 Million | -1.124x | +53.50% |
| 2017-12-31 | $2.59 Million | $-6.27 Million | -2.417x | -41.44% |
| 2016-12-31 | $7.10 Million | $-12.13 Million | -1.709x | -146.94% |
| 2015-12-31 | $-5.10 Million | $-18.56 Million | 3.640x | +144.69% |
| 2014-12-31 | $1.85 Million | $-15.05 Million | -8.147x | -434.94% |
| 2013-12-31 | $8.52 Million | $-12.97 Million | -1.523x | -227.75% |
| 2012-12-31 | $14.05 Million | $-6.53 Million | -0.465x | -38.19% |
| 2011-12-31 | $9.34 Million | $-3.14 Million | -0.336x | -273.93% |
| 2010-12-31 | $10.49 Million | $2.03 Million | 0.193x | +256.55% |
| 2009-12-31 | $13.35 Million | $-1.65 Million | -0.123x | +90.88% |
| 2008-12-31 | $7.34 Million | $-9.94 Million | -1.354x | -209.09% |
| 2007-12-31 | $14.32 Million | $-6.27 Million | -0.438x | -116.74% |
| 2006-12-31 | $1.81 Million | $4.74 Million | 2.617x | +363.45% |
| 2005-12-31 | $3.25 Million | $-3.23 Million | -0.993x | -- |
About NovaBay Pharmaceuticals Inc
NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. T… Read more